Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
mi
from
Doylestown, PA
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
mi
from
Doylestown, PA
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
mi
from
Erie, PA
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
mi
from
Erie, PA
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
mi
from
Hershey, PA
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
mi
from
Hershey, PA
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
mi
from
Philadelphia, PA
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
mi
from
Philadelphia, PA
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
mi
from
Providence, RI
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
mi
from
Providence, RI
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
mi
from
Charleston, SC
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
mi
from
Columbia, SC
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
mi
from
Columbia, SC
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
mi
from
Sioux Falls, SD
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
mi
from
Chattanooga, TN
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
mi
from
Knoxville, TN
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
mi
from
Knoxville, TN
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
mi
from
Knoxville, TN
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
mi
from
Knoxville, TN
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
mi
from
Nashville, TN
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
mi
from
Baytown, TX
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
mi
from
Baytown, TX
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
mi
from
Dallas, TX
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
mi
from
El Paso, TX
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
mi
from
Harlingen, TX
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
mi
from
Harlingen, TX
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
mi
from
Houston, TX
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
mi
from
Houston, TX
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
mi
from
Houston, TX
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
mi
from
Kingwood, TX
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
mi
from
Kingwood, TX
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
mi
from
Southlake, TX
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
mi
from
Southlake, TX
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
mi
from
Richmond, VA
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
mi
from
Richmond, VA
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
mi
from
Roanoake, VA
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
mi
from
Roanoake, VA
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
mi
from
Seattle, WA
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
mi
from
Huntington, WV
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
mi
from
Huntington, WV
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
mi
from
Morgantown, WV
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
mi
from
Morgantown, WV
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
mi
from
Milwaukee, WI
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
Clinical Research Facility
mi
from
Milwaukee, WI
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated:  4/6/2016
mi
from
Buenos Aires,
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.
Status: Enrolling
Updated: 4/6/2016
mi
from
Buenos Aires,
Click here to add this to my saved trials
Clinician Counseling and Cultural Competency to Improve Hypertension Control and Therapy Adherence
Hypertension Control and Therapy Adherence
Status: Enrolling
Updated:  4/6/2016
Boston University School of Medicine
mi
from
Boston, MA
Clinician Counseling and Cultural Competency to Improve Hypertension Control and Therapy Adherence
Hypertension Control and Therapy Adherence
Status: Enrolling
Updated: 4/6/2016
Boston University School of Medicine
mi
from
Boston, MA
Click here to add this to my saved trials
Use Art-assist and Neupogen to Treat Chronic Limb Ischemia
Proteomics and Stem Cell Therapy as a New Vascularization Strategy
Status: Enrolling
Updated:  4/7/2016
University of Chicago
mi
from
Chicago, IL
Use Art-assist and Neupogen to Treat Chronic Limb Ischemia
Proteomics and Stem Cell Therapy as a New Vascularization Strategy
Status: Enrolling
Updated: 4/7/2016
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Alexander City, AL
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Alexander City, AL
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Auburn, AL
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Auburn, AL
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Birmingham, AL
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Huntsville, AL
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Huntsville, AL
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Campe Verde, AZ
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Campe Verde, AZ
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Chandler, AZ
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Chandler, AZ
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Cottonwood, AZ
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Cottonwood, AZ
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Fountain Hills, AZ
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Fountain Hills, AZ
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Mesa, AZ
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Mesa, AZ
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Tucson, AZ
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Fayetteville, AR
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Jonesboro, AR
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Jonesboro, AR
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Little Rock, AR
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Arvin, CA
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Arvin, CA
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Bakersfield, CA
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Chino, CA
Naltrexone/Bupropion Cardiovascular Outcomes Study
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 4 Study to Assess the Effect of Naltrexone Hydrochloride and Bupropion Hydrochloride Extended Release Combination on the Occurrence of Major Adverse Cardiovascular Events in Overweight and Obese Subjects With Cardiovascular Disease
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Chino, CA
Click here to add this to my saved trials